Anika Therapeutics, Inc. (ANIK) NASDAQ
15.22
+0.3(+2.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Anika Therapeutics, Inc.
Address
32 Wiggins Avenue
Bedford, MA 01730
United States of America (the)
Phone
781 457 9000
Sector
Healthcare
Industry
Medical - Devices
Employees
288
First IPO Date
May 03, 1993
Key Executives
| Name | Title | Pay | Year Born |
| Cheryl Renee Blanchard | President, Chief Executive Officer & Director | 1.27M | 1964 |
| David Colleran | Executive VP, General Counsel & Corporate Secretary | 685,104 | 1972 |
| Stephen D. Griffin | Executive Vice President, Chief Financial Officer & Chief Operating Officer | 795,171 | 1986 |
| Ben Joseph | Vice President of Commercial & Corporate Development | 0 | N/A |
| Ian W. McLeod | VP & Chief Accounting Officer | 0 | N/A |
| James Chase | Senior Vice President of International Sales & Marketing | 0 | N/A |
| Mark Namaroff | Vice President of Investor Relations, ESG & Corporate Communications | 0 | 1963 |
| Matthew Hall | Director of Corporate Development & Investor Relations | 0 | N/A |
| Lisa Funiciello | Vice President of Human Resources | 0 | N/A |
| Mira Leiwant | Senior Vice President of Regulatory, Quality & Clinical Affairs | 0 | N/A |
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
